The global anti-hypertensive drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Antihypertensive drugs are defined as a class of drugs that treat hypertension or the more common name high blood pressure. These drugs basically work by preventing the complications of high blood pressure, such as stroke and myocardial infarction. Further, as per the American Heart Association, high blood pressure can lead to heart failure. Globally, almost 15 million people suffer from heart attacks or similar issues, according to the World Heart Federation. Heart disease claims the lives of around 659,000 people in the US each year, accounting for one out of every four mortalities. Between 2016 and 2017, the US spent $363 billion on heart disease. This covers the costs of healthcare services, medications, and lost productivity as a result of mortality.

The global burden of hypertension is a major concern that is accompanied by serious complications such as heart attack, heart failure, and dementia. Therefore, it requires early proper treatment solutions such as anti-hypertensive drugs. Some of the drugs used for the treatment of hypertension include diuretics, ACE inhibitors, and vasodilators. The advent of pipeline drugs for the treatment of hypertensive disorders is one of the major opportunities that are likely to boost the market growth in the near future. There are various other pivotal factors that are driving the global market growth which include the rising incidence and prevalence rate of hypertensive heart diseases, growing awareness programs by government organizations, and the high global healthcare expenditure. However, the side effects of the hypertensive drugs and regulatory compliances may hinder the growth of the global anti-hypertensive drugs market. 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Therapeutic Class

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Pfizer Inc., Merck & Co, Inc., and Abbott Laboratories, among others.

• Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-Hypertensive Drugs Market Report by Segment

By Therapeutic Class

• Diuretics
• Beta Blockers
• Alpha Blockers
• Calcium Channel Blockers
• Angiotensin Converting Enzyme (ACE)
• Angiotensin Receptor Blockers
• Others

Global Anti-Hypertensive Drugs Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa